Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Ladurner

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Structural Biology|January 14, 1999
Upper limit of the time scale for diffusion and chain collapse in chymotrypsin inhibitor 2A G Ladurner, A R Fersht
Journal of Molecular Biology|November 21, 1997
Glutamine, alanine or glycine repeats inserted into the loop of a protein have minimal effects on stability and folding ratesA G Ladurner, A R Fersht
Folding & Design|January 1, 1997
Strain in the folding nucleus of chymotrypsin inhibitor 2A G Ladurner, L S Itzhaki, A R Fersht
Nature|February 16, 1999
The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1S Ryu, S Zhou, A G Ladurner, et al.
Science (New York, N.Y.)|December 11, 1999
Three-dimensional structure of the human TFIID-IIA-IIB complexF Andel, A G Ladurner, C Inouye, et al.
Science (New York, N.Y.)|May 29, 2000
Structure and function of a human TAFII250 double bromodomain moduleR H Jacobson, A G Ladurner, D S King, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998
Synergy between simulation and experiment in describing the energy landscape of protein foldingA G Ladurner, L S Itzhaki, V Daggett, et al.
Journal of Molecular Biology|November 21, 1997
Complementation of peptide fragments of the single domain protein chymotrypsin inhibitor 2A G Ladurner, L S Itzhaki, G de Prat Gay, et al.
Folding & Design|January 1, 1996
Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanismJ L Neira, B Davis, A G Ladurner, et al.
Oncogene|August 4, 2009
Histone macroH2A isoforms predict the risk of lung cancer recurrenceJ C Sporn, G Kustatscher, T Hothorn, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Structural Biology|January 14, 1999
Upper limit of the time scale for diffusion and chain collapse in chymotrypsin inhibitor 2A G Ladurner, A R Fersht
Journal of Molecular Biology|November 21, 1997
Glutamine, alanine or glycine repeats inserted into the loop of a protein have minimal effects on stability and folding ratesA G Ladurner, A R Fersht
Folding & Design|January 1, 1997
Strain in the folding nucleus of chymotrypsin inhibitor 2A G Ladurner, L S Itzhaki, A R Fersht
Nature|February 16, 1999
The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1S Ryu, S Zhou, A G Ladurner, et al.
Science (New York, N.Y.)|December 11, 1999
Three-dimensional structure of the human TFIID-IIA-IIB complexF Andel, A G Ladurner, C Inouye, et al.
Science (New York, N.Y.)|May 29, 2000
Structure and function of a human TAFII250 double bromodomain moduleR H Jacobson, A G Ladurner, D S King, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998
Synergy between simulation and experiment in describing the energy landscape of protein foldingA G Ladurner, L S Itzhaki, V Daggett, et al.
Journal of Molecular Biology|November 21, 1997
Complementation of peptide fragments of the single domain protein chymotrypsin inhibitor 2A G Ladurner, L S Itzhaki, G de Prat Gay, et al.
Folding & Design|January 1, 1996
Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanismJ L Neira, B Davis, A G Ladurner, et al.
Oncogene|August 4, 2009
Histone macroH2A isoforms predict the risk of lung cancer recurrenceJ C Sporn, G Kustatscher, T Hothorn, et al.
Pageof 2